Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to $439855.0.

  • Outlook Therapeutics' Other Working Capital Changes rose 10780.84% to $439855.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.9 million, marking a year-over-year increase of 8433.06%. This contributed to the annual value of -$8.0 million for FY2025, which is 26346.64% down from last year.
  • According to the latest figures from Q4 2025, Outlook Therapeutics' Other Working Capital Changes is $439855.0, which was up 10780.84% from -$1.8 million recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Other Working Capital Changes ranged from a high of $439855.0 in Q4 2025 and a low of -$5.6 million during Q4 2024